Apex Healthcare Bhd (7090) - Total Liabilities

Latest as of September 2025: RM219.04 Million MYR ≈ $54.99 Million USD

Based on the latest financial reports, Apex Healthcare Bhd (7090) has total liabilities worth RM219.04 Million MYR (≈ $54.99 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Apex Healthcare Bhd (7090) equity growth momentum to track the company's year-over-year net asset growth rate.

Apex Healthcare Bhd - Total Liabilities Trend (2012–2024)

This chart illustrates how Apex Healthcare Bhd's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Apex Healthcare Bhd to measure how efficiently the company converts operating cash flow to free cash.

Apex Healthcare Bhd Competitors by Total Liabilities

The table below lists competitors of Apex Healthcare Bhd ranked by their total liabilities.

Company Country Total Liabilities
Coca-Cola Embonor S.A
SN:EMBONOR-B
Chile CL$622.25 Billion
Stenhus Fastigheter I Norden AB
ST:SFAST
Sweden Skr8.96 Billion
Shanghai Shine-Link Intl
SHG:603648
China CN¥562.95 Million
Hyosung Advanced Materials Corp
KO:298050
Korea ₩3.08 Trillion
Shanghai W Ibeda High Tech Group Co Ltd
SHG:688071
China CN¥1.23 Billion
Diamond Hill Investment Group Inc
NASDAQ:DHIL
USA $83.97 Million
Zhejiang Jiaxin Silk Corp Ltd
SHE:002404
China CN¥1.47 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Apex Healthcare Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Apex Healthcare Bhd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.35 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.28 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.22 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Apex Healthcare Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Apex Healthcare Bhd (2012–2024)

The table below shows the annual total liabilities of Apex Healthcare Bhd from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 RM219.27 Million
≈ $55.05 Million
+7.30%
2023-12-31 RM204.34 Million
≈ $51.30 Million
+9.37%
2022-12-31 RM186.83 Million
≈ $46.91 Million
+7.82%
2021-12-31 RM173.29 Million
≈ $43.51 Million
+13.30%
2020-12-31 RM152.95 Million
≈ $38.40 Million
-2.97%
2019-12-31 RM157.64 Million
≈ $39.58 Million
+2.38%
2018-12-31 RM153.97 Million
≈ $38.66 Million
+35.46%
2017-12-31 RM113.67 Million
≈ $28.54 Million
+6.80%
2016-12-31 RM106.44 Million
≈ $26.72 Million
+4.35%
2015-12-31 RM102.00 Million
≈ $25.61 Million
+8.51%
2014-12-31 RM94.00 Million
≈ $23.60 Million
+20.51%
2013-12-31 RM78.00 Million
≈ $19.58 Million
+5.41%
2012-12-31 RM74.00 Million
≈ $18.58 Million
--

About Apex Healthcare Bhd

KLSE:7090 Malaysia Medical Distribution
Market Cap
$473.43 Million
RM1.89 Billion MYR
Market Cap Rank
#12507 Global
#133 in Malaysia
Share Price
RM2.61
Change (1 day)
+0.00%
52-Week Range
RM2.27 - RM2.64
All Time High
RM3.34
About

Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, ant… Read more